Thoracic oncology
PG1 Postgraduate course
Lung cancer: the key multidisciplinary approach
Clinical
Valuable team work together with you by ERS, ATS, ESR, ESTS, ESTRO and IASLC – the diagnostic part
Registration for this session is additional to the congress registration fee and is €220 standard and €242 on site.
Aims : to describe modern diagnostic and therapeutic approaches that can substantially improve the prognosis of lung cancer patients; to enable participants close interaction with the multidisciplinary faculty from leading international societies in the field of lung cancer and by that learn how to deliver best care to lung cancer patients.
Target audience :
Clinical researcher, General practitioner, Nurse, Pathologist, Patient, Physiotherapist, Radiologist, Student, Thoracic oncologist, Thoracic surgeon, Trainee, Adult pulmonologist/Clinician
Methods :
Endoscopy and interventional pulmonology, Imaging, Surgery
09:30
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
D. Arenberg(Ann Arbor, United States)
COI
-
Description
1
81
10:00
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
T. Blum(Berlin, Germany)
COI
-
Description
2
82
10:30
How (molecular) pathologists can profile patients
S. Stephan-Falkenau(Berlin, Germany)
COI
-
Description
3
83
11:00
New insights into lung cancer: what radiologists can contribute to diagnosis and staging
A. Snoeckx(Edegem (Antwerp), Belgium)
COI
-
Description
4
84
12:00
Group assignment
T. Blum(Berlin, Germany)
COI
D. Arenberg(Ann Arbor, United States)
COI
S. Stephan-Falkenau(Berlin, Germany)
COI
A. Snoeckx(Edegem (Antwerp), Belgium)
COI
6
86
14:00
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
M. Paats(Rotterdam, Netherlands)
COI
-
Description
8
88
14:30
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon
N. Novoa(Majadahonda, Spain)
COI
-
Description
9
89
15:00
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist
D. De Ruysscher(Maastricht, Netherlands)
COI
10
90
15:30
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist
P. Tomasini(Marseille, France)
COI
11
91
16:30
Group assignment
P. Tomasini(Marseille, France)
COI
N. Novoa(Majadahonda, Spain)
COI
D. De Ruysscher(Maastricht, Netherlands)
COI
M. Paats(Rotterdam, Netherlands)
COI
13
93
. . .